World Health Organization site
Skip Navigation Links

Main
Note: This record shows only 22 elements of the WHO Trial Registration Data Set. To view changes that have been made to the source record, or for additional information about this trial, click on the URL below to go to the source record in the primary register.
Register: ClinicalTrials.gov
Last refreshed on: 12 December 2020
Main ID:  NCT04115423
Date of registration: 02/10/2019
Prospective Registration: Yes
Primary sponsor: Sungkyunkwan University
Public title: A Retrospective Cohort Study on the Risk of Serious Infections in Rheumatoid Arthritis Patients Receiving Tocilizumab
Scientific title: A Retrospective Cohort Study to Examine the Risk of Serious Infections in Rheumatoid Arthritis Patients Receiving Tocilizumab Compared With Tumor Necrosis Factor Inhibitors Using the National Health Insurance Database
Date of first enrolment: April 1, 2020
Target sample size: 9508
Recruitment status: Active, not recruiting
URL:  https://clinicaltrials.gov/show/NCT04115423
Study type:  Observational
Study design:   
Phase: 
Countries of recruitment
Korea, Republic of
Contacts
Name:     Ju-Young Shin, Ph.D
Address: 
Telephone:
Email:
Affiliation:  Sungkyunkwan University
Key inclusion & exclusion criteria

Inclusion Criteria:

- Individuals who had a diagnosis of rheumatoid arthritis (ICD-10 codes: M05-06) between
2013 and 2018

Exclusion Criteria:

- Individuals less than 18 years of age

- Having no records of prescription of tocilizumab or TNFi at least once between 2013
and 2018



Age minimum: 18 Years
Age maximum: N/A
Gender: All
Health Condition(s) or Problem(s) studied
Infection
Rheumatoid Arthritis
Intervention(s)
Drug: Tocilizumab
Drug: Tumor Necrosis Factor Inhibitor (etanercept, infliximab, adalimumab, and golimumab)
Primary Outcome(s)
Hazard ratio for serious infections [Time Frame: January 2013 to December 2018]
Secondary Outcome(s)
Hazard ratio for six subdivided groups of serious infections by organ class [Time Frame: January 2013 to December 2018]
Secondary ID(s)
SKKU-2019-TCZ
Source(s) of Monetary Support
Please refer to primary and secondary sponsors
Secondary Sponsor(s)
Ministry of Food and Drug Safety, Korea
Ethics review
Results
Results available:
Date Posted:
Date Completed:
URL:
Disclaimer: Trials posted on this search portal are not endorsed by WHO, but are provided as a service to our users. In no event shall the World Health Organization be liable for any damages arising from the use of the information linked to in this section. None of the information obtained through use of the search portal should in any way be used in clinical care without consulting a physician or licensed health professional. WHO is not responsible for the accuracy, completeness and/or use made of the content displayed for any trial record.
Copyright - World Health Organization - Version 3.6 - Version history